Fu Juan, Jiang Yi-guo, Ju Ying, Shen Yue-lan, Chen Xue-min
Department of Occupational and Environmental Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Aug;43(8):714-7.
To establish the stable inhibition of HER2/neu expression by vector-mediated small hairpin RNA in malignant transformed human bronchial epithelial cell line induced by anti-benzo(a)pyrene-trans-7, 8-dihydrodiol-9, 10-epoxide (anti-BPDE).
The pSIREN-RetroQ-neu recombinant vector targeting HER2/neu was constructed and confirmed by restriction and sequencing analysis, then it was transfected into anti-BPDE malignant transformed 16HBE cells (16HBE-T) through lipofectamine 2000. The control groups included the 16HBE-T cells transfected with negative control vector (negative control) and 16HBE-T. The cells transfected with vectors were screened by puromycin. The HER2/neu mRNA and protein expressions in the vector-transfected 16HBE-T cells were detected by RT-PCR and Western blot method respectively.
The pSIREN-RetroQ-neu recombinant vector which inhibited HER2/neu mRNA and protein expressions in the 16HBE-T was constructed. The level of HER2/neu mRNA in the 16HBE-T cells transfected with pSIREN-RetroQ-neu was significantly reduced as compared to the negative control and blank control cells (0.114 +/- 0.003 vs.blank control 0.186 +/- 0.001, t = 39.154, P < 0.05; and negative control 0.182 +/- 0.015, t = 7.564, P < 0.05), while its level did not differ significantly between negative control cells and blank control of 16HBE-T (t = -0.409, P > 0.05). HER2/neu protein level in pSIREN-RetroQ-neu transfected cells was inhibited by 40% and 39% respectively.
Plasmid-based shRNA expression systems targeted against HER2/neu gene were generated successfully, which resulted in down-regulation of HER2/neu gene expression in the 16HBE-T efficiently.
通过载体介导的小发夹RNA在抗苯并(a)芘-反式-7,8-二氢二醇-9,10-环氧化物(anti-BPDE)诱导的恶性转化人支气管上皮细胞系中建立对HER2/neu表达的稳定抑制。
构建靶向HER2/neu的pSIREN-RetroQ-neu重组载体,经酶切和测序分析鉴定后,通过脂质体2000转染至anti-BPDE恶性转化的16HBE细胞(16HBE-T)。对照组包括转染阴性对照载体的16HBE-T细胞(阴性对照)和16HBE-T。用嘌呤霉素筛选转染载体的细胞。分别采用RT-PCR和Western blot法检测转染载体的16HBE-T细胞中HER2/neu mRNA和蛋白表达。
构建了抑制16HBE-T中HER2/neu mRNA和蛋白表达的pSIREN-RetroQ-neu重组载体。与阴性对照和空白对照细胞相比,转染pSIREN-RetroQ-neu的16HBE-T细胞中HER2/neu mRNA水平显著降低(0.114±0.003 vs.空白对照0.186±0.001,t=39.154,P<0.05;与阴性对照0.182±0.015,t=7.564,P<0.05),而阴性对照细胞与16HBE-T空白对照之间其水平差异无统计学意义(t=-0.409,P>0.05)。pSIREN-RetroQ-neu转染细胞中HER2/neu蛋白水平分别被抑制40%和39%。
成功构建了靶向HER2/neu基因的基于质粒的shRNA表达系统,有效下调了16HBE-T中HER2/neu基因的表达。